EP3665192
ERFÐABREYTTUR TRANSFERRÍN-VIÐTAKI SEM BINDUR FJÖLPETPTÍÐ
:
EP einkaleyfi í gildi á Íslandi:
10.8.2018:
12.7.2023:
18756531.2
:
25.9.2023:
15.11.2023
:
9.8.2038:
9.8.2025:
31.8.2025
:
ENGINEERED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
10.8.2018
12.7.2023
25.9.2023
15.11.2023
9.8.2025
:
Denali Therapeutics Inc.:
161 Oyster Point Boulevard, South San Francisco, California 94080, US
:
CHEN, Xiaocheng:
South San Francisco California 94080, US
:
DENNIS, Mark S.:
South San Francisco California 94080, US
:
KARIOLIS, Mihalis:
South San Francisco California 94080, US
:
SILVERMAN, Adam P.:
South San Francisco California 94080, US
:
SRIVASTAVA, Ankita:
South San Francisco California 94080, US
:
WATTS, Ryan J.:
South San Francisco California 94080, US
:
WELLS, Robert C.:
South San Francisco California 94080, US
:
ZUCHERO, Joy Yu:
South San Francisco California 94080, US
:
Budde Schou A/S:
Dronningens Tværgade 30, DK
:
201762543658 P:
10.8.2017:
US
:
201762583314 P:
8.11.2017:
US
:
PCT/US2018/018371:
15.2.2018:
WO
:
US2018046199:
10.8.2018
:
C07K 14/79, C07K 14/705, A61K 38/00, A61K 38/40, A61K 39/00, A61K 47/68, A61P 25/28, C07K 16/00, C07K 16/28, C07K 16/40
: 6
: 27.10.2023
: 9.8.2024
: Árnason Faktor ehf.
: 7
: 9.7.2024
: 9.8.2025
: Árnason Faktor ehf.